Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Treatment
86 results:

  • 1. Location matters: spatial dynamics of tumor-infiltrating T cell subsets is prognostic in colon cancer.
    Zhu H; Roelands J; Ahmed EI; Stouten I; Hoorntje R; van Vlierberghe RLP; Ijsselsteijn ME; Lei X; de Miranda NFCC; Tollenaar RAEM; Vahrmeijer AL; Bedognetti D; Hendrickx WRL; Kuppen PJK
    Front Immunol; 2024; 15():1293618. PubMed ID: 38375478
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. FSTL3 promotes tumor immune evasion and attenuates response to anti-PD1 therapy by stabilizing c-Myc in colorectal cancer.
    Li H; Zheng N; Guo A; Tang W; Li M; Cao Y; Ma X; Cao H; Ma Y; Wang H; Zhao S
    Cell Death Dis; 2024 Feb; 15(2):107. PubMed ID: 38302412
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Integrin-linked kinase expression in myeloid cells promotes colon tumorigenesis.
    Ahmed AU; Almasabi S; Firestein R; Williams BRG
    Front Immunol; 2023; 14():1270194. PubMed ID: 38077324
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. pH-Responsive Zinc Ion Regulating Immunomodulatory Nanoparticles for Effective cancer Immunotherapy.
    Lim B; Kim KS; Na K
    Biomacromolecules; 2023 Sep; 24(9):4263-4273. PubMed ID: 37616157
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. IMMUNOREACT 0: Biopsy-based immune biomarkers as predictors of response to neoadjuvant therapy for rectal cancer-A systematic review and meta-analysis.
    Stepanyan A; Fassan M; Spolverato G; Castagliuolo I; Scarpa M; Scarpa M;
    Cancer Med; 2023 Sep; 12(17):17878-17890. PubMed ID: 37537787
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Immune microenvironment and lymph node yield in colorectal cancer.
    Lee SH; Pankaj A; Neyaz A; Ono Y; Rickelt S; Ferrone C; Ting D; Patil DT; Yilmaz O; Berger D; Deshpande V; Yılmaz O
    Br J Cancer; 2023 Oct; 129(6):917-924. PubMed ID: 37507544
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Muscarinic Acetylcholine Receptor M3 Expression and Survival in Human colorectal Carcinoma-An Unexpected Correlation to Guide Future treatment?
    Lobbes LA; Schütze MA; Droeser R; Arndt M; Pozios I; Lauscher JC; Hering NA; Weixler B
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175905
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Neoadjuvant intratumoral influenza vaccine treatment in patients with proficient mismatch repair colorectal cancer leads to increased tumor infiltration of CD8+ T cells and upregulation of PD-L1: a phase 1/2 clinical trial.
    Gögenur M; Balsevicius L; Bulut M; Colak N; Justesen TF; Fiehn AK; Jensen MB; Høst-Rasmussen K; Cappelen B; Gaggar S; Tajik A; Zahid JA; Bennedsen ALB; D'Ondes TDB; Raskov H; Sækmose SG; Hansen LB; Salanti A; Brix S; Gögenur I
    J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37172969
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. China special issue on gastrointestinal tumors-Regulatory-immunoscore-A novel indicator to guide precision adjuvant chemotherapy in colorectal cancer.
    Fang L; Yao Y; Guan X; Liao Y; Wang B; Cui L; Han S; Zou H; Su D; Ma Y; Liu B; Wang Y; Huang R; Ruan Y; Yu X; Yao Y; Liu C; Zhang Y
    Int J Cancer; 2023 Dec; 153(11):1904-1915. PubMed ID: 37085990
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Vascular endothelial growth factor inhibitors promote antitumor responses via tumor microenvironment immunosuppression in advanced colorectal cancer.
    Hamada Y; Tanoue K; Kita Y; Tanabe K; Hokonohara K; Wada M; Hozaka Y; Oi H; Nakayama C; Higashi M; Arigami T; Mori S; Ohtsuka T
    Scand J Gastroenterol; 2023; 58(9):1009-1020. PubMed ID: 36987919
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Comprehensive evaluation of the tumor immune microenvironment and its dynamic changes in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy: From the phase II ADORE study.
    Cho H; Kim JE; Hong YS; Kim SY; Kim J; Ryu YM; Kim SY; Kim TW
    Oncoimmunology; 2022; 11(1):2148374. PubMed ID: 36451674
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. MiR-125b-5p modulates the function of regulatory T cells in tumor microenvironment by targeting TNFR2.
    Jiang M; Yang Y; Niu L; Li P; Chen Y; Liao P; Wang Y; Zheng J; Chen F; He H; Li H; Chen X
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36319063
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A study on the correlation between M2 macrophages and regulatory T cells in the progression of colorectal cancer.
    Chen Y; Gao Y; Ma X; Wang Y; Liu J; Yang C; Wang Y; Bao C; Song X; Feng Y; Sun Y; Qiao S
    Int J Biol Markers; 2022 Dec; 37(4):412-420. PubMed ID: 36285512
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The immune microenvironment landscape shows treatment-specific differences in rectal cancer patients.
    Graham Martínez C; Barella Y; Kus Öztürk S; Ansems M; Gorris MAJ; van Vliet S; Marijnen CAM; Nagtegaal ID
    Front Immunol; 2022; 13():1011498. PubMed ID: 36238289
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. GITR Ligation Improves Anti-PD1-Mediated Restoration of Human MMR-Proficient colorectal Carcinoma Tumor-Derived T Cells.
    Rakké YS; Campos Carrascosa L; van Beek AA; de Ruiter V; van Gemerden RS; Doukas M; Doornebosch PG; Vermaas M; Ter Borg S; van der Harst E; Coene PPLO; Kliffen M; Grünhagen DJ; Verhoef C; IJzermans JNM; Kwekkeboom J; Sprengers D
    Cell Mol Gastroenterol Hepatol; 2023; 15(1):77-97. PubMed ID: 36155259
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Immune Evasion and Drug Resistance Mediated by USP22 in cancer: Novel Targets and Mechanisms.
    Guo J; Zhao J; Fu W; Xu Q; Huang D
    Front Immunol; 2022; 13():918314. PubMed ID: 35935969
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Altered mucosal immunity in HIV-positive colon adenoma: decreased CD4
    Matsubara Y; Ota Y; Tanaka Y; Denda T; Hijikata Y; Boku N; Lim LA; Hirata Y; Tsurita G; Adachi E; Yotsuyanagi H
    Int J Clin Oncol; 2022 Aug; 27(8):1321-1330. PubMed ID: 35643870
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The TLR7/8 agonist R848 optimizes host and tumor immunity to improve therapeutic efficacy in murine lung cancer.
    Zhou J; Xu Y; Wang G; Mei T; Yang H; Liu Y
    Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35552764
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Mutations of PI3K-AKT-mTOR pathway as predictors for immune cell infiltration and immunotherapy efficacy in dMMR/MSI-H gastric adenocarcinoma.
    Wang Z; Wang X; Xu Y; Li J; Zhang X; Peng Z; Hu Y; Zhao X; Dong K; Zhang B; Gao C; Zhao X; Chen H; Cai J; Bai Y; Sun Y; Shen L
    BMC Med; 2022 Apr; 20(1):133. PubMed ID: 35443723
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Effect of Astragali Radix-Curcumae Rhizoma compatibility combined with 5-fluorouracil on Th17/Treg balance and tumor-related mRNA and protein expression in orthotopic xenograft model mice of CT26.WT colorectal carcinoma].
    Guo WH; Qi ZC; Guan HQ; Liu TT; Liang L; Yu QH; Liang Y; Tang DC
    Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(1):167-175. PubMed ID: 35178924
    [TBL] [Abstract] [Full Text] [Related]  


    of 5.